CCI
MDCO

Columbus Circle Investors’s Medicines Co MDCO Stock Holding History

Columbus Circle Investors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-534,761
Closed -$15.2M – 317
2014
Q1 		$15.2M Sell
534,761
-197,829
-27% -$6.55M 0.1% 188
2013
Q4 		$28.3M Buy
732,590
+229,125
+46% +$8.19M 0.19% 133
2013
Q3 		$16.9M Sell
503,465
-276,089
-35% -$8.79M 0.12% 190
2013
Q2 		$24M Buy
+779,554
New +$26.1M 0.19% 132

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Columbus Circle Investors's MDCO Position: Q2 2014 in Review

Columbus Circle Investors sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 534,761 shares — an estimated $15.2M sold.

Columbus Circle Investors first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $28.3M in Q4 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Columbus Circle Investors reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 534,761 Medicines Co shares in Q2 2014, an estimated $15.2M.
  • Columbus Circle Investors first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Columbus Circle Investors's Medicines Co position peaked at $28.3M in Q4 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Columbus Circle Investors's 13F filing for Q2 2014, filed 31 Jul 2014.